Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia
Open Access
- 8 August 2016
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (4) , 2296-2300
Abstract
MicroRNAs (miRs) are small non‑coding RNAs that play important roles in cell differentiation and survival. Abnormal expression of miRs has been demonstrated in numerous types of cancer, including acute myeloid leukaemia (AML). The aim of the present study was to evaluate miR‑181 expression at diagnosis and following the completion of chemotherapy in AML patients, with regard to clinical response and outcome, particularly in patients treated with azacitidine. miR‑181 expression was analysed using reverse transcription‑quantitative polymerase chain reaction in 95 bone marrow specimens from newly diagnosed AML patients and in 20 healthy subjects for comparison. The results revealed upregulated miR‑181 expression in the total cohort of AML patients, which was correlated with longer survival. However, in a subset of older AML patients treated with azacitidine, low miR‑181 expression at diagnosis was a predictor for complete remission and prolonged survival. The findings indicated that miR‑181 has an important role in AML and determines response to azacitidine treatment in older AML patients.Keywords
This publication has 32 references indexed in Scilit:
- Concise Drug Review: Azacitidine and DecitabineThe Oncologist, 2013
- Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLBlood, 2012
- Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapyInternational Journal of Oncology, 2011
- Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2010
- Differential expression of specific microRNA and their targets in acute myeloid leukemiaAmerican Journal of Hematology, 2010
- Micro-RNAs and copy number changes: New levels of gene regulation in acute myeloid leukemiaChemico-Biological Interactions, 2010
- Identification of acute myeloid leukaemia associated microRNA expression patternsBritish Journal of Haematology, 2007
- MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysisLeukemia, 2007
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001